Chagas' Disease: Update on Current Diagnosis
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
BORGES-NETO, Salvador
Citação
CURRENT CARDIOVASCULAR IMAGING REPORTS, v.9, n.12, article ID 33, 9p, 2016
Resumo
Purpose of Review Chagas' disease has become an emerging health problem due to increased migration. In the present review, we have summarized the usefulness of non-invasive imaging tools for the diagnosis of cardiac involvement in Chagas' disease, with emphasis on modern technologies. M-mode, bidimensional (2-D), and three-dimensional (3-D) echocardiographies may allow the evaluation of left ventricular (LV) regional and global contractile function, right ventricle (RV) impairment, evidence of aneurysms and thrombi, and assessment of diastolic function in any stage of the disease. Recent Findings New modalities such as strain and speckle-tracking imaging have brought non-invasive indices to the understanding of the mechanisms of cardiac dyssynchrony. The assessment of cardiac autonomic denervation using I-123-metaiodobenzylguanidine (I-123-MIBG), LV, and RV systolic function and the study of LV mechanical dyssynchrony by gated cardiac blood pool are available in current nuclear imaging for patients with Chagas' disease. The findings of myocardial fibrosis by cardiac magnetic resonance (CMR), mainly in inferolateral regions, are a marker of subclinical involvement and worse prognosis in Chagas' disease, even in patients with preserved ventricular function. Summary The detection and quantification of early signs of heart involvement by new technologies should be useful for risk stratification and in the clinical decision process for new therapeutic methods and could improve the natural history of the disease.
Palavras-chave
Chagas' disease, Ventricular dysfunction, Myocardial perfusion imaging, Cardiac magnetic resonance, Fibrosis, Cardiomyopathy
Referências
- Andrade JP, 2010, ARQ BRAS CARDIOL, V96, P434
- Barbosa MM, 2014, ECHOCARDIOGR-J CARD, V31, P623, DOI 10.1111/echo.12426
- Bocchi E. A., 1998, Echocardiography, V15, P279
- Botvinick EH, 2009, J NUCL CARDIOL, V16, P846, DOI 10.1007/s12350-009-9151-4
- Brandao SCS, 2009, EUR J NUCL MED MOL I, V36, P986, DOI 10.1007/s00259-008-1029-1
- Vieira MLC, 2013, ARQ BRAS CARDIOL, V101, P43, DOI 10.5935/abc.20130112
- Chen J, 2005, J NUCL CARDIOL, V12, P687, DOI 10.1016/j.nuclcard.2005.06.088
- DiCarli MF, 1997, NEW ENGL J MED, V336, P1208, DOI 10.1056/NEJM199704243361703
- Falchetto EB, 2015, GLOBAL HEART, V10, P181
- Fiorelli AI, 2005, TRANSPLANT P, V37, P2793, DOI 10.1016/j.transproceed.2005.05.038
- Freitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025
- Gimenes VML, 2008, J AM SOC ECHOCARDIOG, V21, P1229, DOI 10.1016/j.echo.2008.08.003
- HAGAR JM, 1991, NEW ENGL J MED, V325, P763, DOI 10.1056/NEJM199109123251103
- Hahn RT, 2013, J AM SOC ECHOCARDIOG, V26, P921, DOI 10.1016/j.echo.2013.07.009
- Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4
- Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
- Hotta VT, 2012, ECHOCARDIOGR-J CARD, V29, P678, DOI 10.1111/j.1540-8175.2011.01658.x
- Hotta VT, 2011, ARQ BRAS CARDIOL, V97, P111
- Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f
- Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105
- Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003
- Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010
- Lee-Felker SA, 2016, CLIN RADIOL, V71
- Mady C, 1999, AM J CARDIOL, V84, P354, DOI 10.1016/S0002-9149(99)00295-7
- Mancuso FJN, 2011, J AM SOC ECHOCARDIOG, V24, P526, DOI 10.1016/j.echo.2011.01.013
- Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296
- MARINNETO JA, 1992, AM J CARDIOL, V69, P780, DOI 10.1016/0002-9149(92)90505-S
- Mello Ronaldo Peixoto de, 2012, Arq Bras Cardiol, V98, P421
- Pereira FTM, 2016, ARQ BRAS CARDIOL, V107, P99, DOI 10.5935/abc.20160101
- MORRIS SA, 1990, CIRCULATION, V82, P1900
- Narula J, 2015, J NUCL MED, V56, P1011, DOI 10.2967/jnumed.115.156406
- Nishioka SAD, 2007, J NUCL CARDIOL, V14, P852, DOI 10.1016/j.nuclcard.2007.08.004
- Nunes MCP, 2009, J AM SOC ECHOCARDIOG, V22, P82, DOI 10.1016/j.echo.2008.11.015
- Peix A, 2013, ARQ BRAS CARDIOL, V100, P114, DOI 10.5935/abc.20130023
- Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046
- Duarte JDP, 2011, ARQ BRAS CARDIOL, V96, P300
- Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75
- Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265
- Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241
- Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
- Rassi DD, 2014, ARQ BRAS CARDIOL, V102, P245, DOI 10.5935/abc.20140003
- Regueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089
- Rochitte CE, 2007, ARTIF ORGANS, V31, P259, DOI 10.1111/j.1525-1594.2007.00373.x
- Rochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067
- Rodriguez-Zanella H, 2015, INT J CARDIOL, V187, P78, DOI 10.1016/j.ijcard.2015.03.337
- Sarabanda AVL, 2005, INT J CARDIOL, V102, P9, DOI 10.1016/j.ijcard.2004.03.087
- Simoes MV, 2000, AM J CARDIOL, V86, P975, DOI 10.1016/S0002-9149(00)01133-4
- Stockburger M, 2016, CLIN RES CARDIOL, V105, P944, DOI 10.1007/s00392-016-1003-z
- Tassi EM, 2014, ARQ BRAS CARDIOL, V102, P456, DOI 10.5935/abc.20140052
- TORRES FW, 1995, AM HEART J, V129, P995, DOI 10.1016/0002-8703(95)90122-1
- TSAN MF, 1985, J NUCL MED, V26, P88
- Tsang W, 2016, JACC-CARDIOVASC IMAG, V9, P769, DOI 10.1016/j.jcmg.2015.12.020
- Vieira MLC, 2008, ARQ BRAS CARDIOL, V91, P156, DOI 10.1590/S0066-782X2008001500004
- Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960
- Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018